ES471672A1 - Un procedimiento para la preparacion de un peptido - Google Patents
Un procedimiento para la preparacion de un peptidoInfo
- Publication number
- ES471672A1 ES471672A1 ES471672A ES471672A ES471672A1 ES 471672 A1 ES471672 A1 ES 471672A1 ES 471672 A ES471672 A ES 471672A ES 471672 A ES471672 A ES 471672A ES 471672 A1 ES471672 A1 ES 471672A1
- Authority
- ES
- Spain
- Prior art keywords
- psychopharmacological
- therapeutic administration
- peptides suitable
- group
- hydroxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 2
- 230000001003 psychopharmacologic effect Effects 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
- 125000001118 alkylidene group Chemical group 0.000 abstract 1
- 125000000539 amino acid group Chemical group 0.000 abstract 1
- 125000003277 amino group Chemical group 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 125000004356 hydroxy functional group Chemical group O* 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/16—Oxytocins; Vasopressins; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S930/00—Peptide or protein sequence
- Y10S930/01—Peptide or protein sequence
- Y10S930/26—Containing cys-cys disulfide bridge between nonadjacent cysteine residues
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Abstract
Se describen nuevos péptidos de fórmula: **(Fórmula)** (junto con composiciones farmacéuticas efectiva de los mismos), donde X1 y X2 representan un grupo hidroxi o amino y B representa: (1) hidroxi o (2) un resto de un aminoácido seleccionado entre el grupo formado por L-Asp-OH, L-Asn-OH, L-Glu-OH, L-Gln-OH, L-Ser-OH o HN-A-COOH, donde A es un grupo alquilideno de 1 a 6 átomos de carbono; o un derivado funcional de los mismos. Estos péptidos presentan propiedades psicofarmacológicas; son adecuados para el tratamiento de ciertos trastornos mentales en los que se desea estimular la función cerebral, v.g. para el tratamiento de la senibilidad y/o de la amnesia.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NL7707781A NL7707781A (nl) | 1977-07-13 | 1977-07-13 | Psychofarmacologische peptiden. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES471672A1 true ES471672A1 (es) | 1979-09-16 |
Family
ID=19828866
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES471672A Expired ES471672A1 (es) | 1977-07-13 | 1978-07-12 | Un procedimiento para la preparacion de un peptido |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US4203975A (es) |
| JP (1) | JPS5419934A (es) |
| AU (1) | AU519567B2 (es) |
| BE (1) | BE868953A (es) |
| CA (1) | CA1108123A (es) |
| DE (1) | DE2830489A1 (es) |
| DK (1) | DK149454C (es) |
| ES (1) | ES471672A1 (es) |
| FI (1) | FI67367C (es) |
| FR (1) | FR2397395A1 (es) |
| GB (1) | GB2001076B (es) |
| IE (1) | IE47547B1 (es) |
| LU (1) | LU79960A1 (es) |
| NL (1) | NL7707781A (es) |
| SE (1) | SE443789B (es) |
| ZA (1) | ZA783713B (es) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU530062B2 (en) * | 1979-02-21 | 1983-06-30 | Akzo N.V. | Psycho-pharmacological peptides |
| JPH0195597U (es) * | 1987-12-17 | 1989-06-23 | ||
| EP3000836B1 (en) * | 2013-05-22 | 2018-12-26 | National Institute of Advanced Industrial Science and Technology | Photodegradable crosslinking agent |
| NZ714555A (en) * | 2013-09-17 | 2020-03-27 | Obi Pharma Inc | Compositions of a carbohydrate vaccine for inducing immune responses and uses thereof in cancer treatment |
| US10980894B2 (en) | 2016-03-29 | 2021-04-20 | Obi Pharma, Inc. | Antibodies, pharmaceutical compositions and methods |
| AU2017252128B2 (en) | 2016-04-22 | 2024-06-06 | Obi Pharma, Inc. | Cancer immunotherapy by immune activation or immune modulation via Globo series antigens |
| JP2019527690A (ja) | 2016-07-27 | 2019-10-03 | オービーアイ ファーマ，インコーポレイテッド | 免疫原性／治療用グリカン組成物およびその使用 |
| EP3491026A4 (en) | 2016-07-29 | 2020-07-29 | OBI Pharma, Inc. | HUMAN ANTIBODIES, PHARMACEUTICAL COMPOSITIONS AND METHODS |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3803119A (en) * | 1970-04-20 | 1974-04-09 | Daiichi Seiyaku Co | Pantetheine-s-sulfonic acid derivatives and salts thereof |
| NL175293C (nl) * | 1972-02-08 | 1984-10-16 | Akzo Nv | Werkwijze ter bereiding of vervaardiging van een farmaceutisch preparaat met psychofarmacologische werking, alsmede werkwijze voor het bereiden van een van vasopressine afgeleid peptide. |
-
1977
- 1977-07-05 AU AU37780/78A patent/AU519567B2/en not_active Expired
- 1977-07-13 NL NL7707781A patent/NL7707781A/xx not_active Application Discontinuation
-
1978
- 1978-06-28 IE IE1291/78A patent/IE47547B1/en unknown
- 1978-06-28 ZA ZA00783713A patent/ZA783713B/xx unknown
- 1978-06-30 US US05/921,067 patent/US4203975A/en not_active Expired - Lifetime
- 1978-07-07 FI FI782195A patent/FI67367C/fi not_active IP Right Cessation
- 1978-07-07 GB GB7829197A patent/GB2001076B/en not_active Expired
- 1978-07-11 DE DE19782830489 patent/DE2830489A1/de not_active Withdrawn
- 1978-07-12 SE SE7807759A patent/SE443789B/sv not_active IP Right Cessation
- 1978-07-12 LU LU79960A patent/LU79960A1/xx unknown
- 1978-07-12 BE BE189247A patent/BE868953A/xx unknown
- 1978-07-12 CA CA307,217A patent/CA1108123A/en not_active Expired
- 1978-07-12 JP JP8500278A patent/JPS5419934A/ja active Granted
- 1978-07-12 ES ES471672A patent/ES471672A1/es not_active Expired
- 1978-07-13 DK DK314978A patent/DK149454C/da not_active IP Right Cessation
- 1978-07-13 FR FR7821087A patent/FR2397395A1/fr active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| CA1108123A (en) | 1981-09-01 |
| IE781291L (en) | 1979-01-13 |
| JPS6220200B2 (es) | 1987-05-06 |
| DE2830489A1 (de) | 1979-01-25 |
| BE868953A (fr) | 1979-01-12 |
| DK314978A (da) | 1979-01-14 |
| ZA783713B (en) | 1979-07-25 |
| SE7807759L (sv) | 1979-01-14 |
| FI782195A (fi) | 1979-01-14 |
| IE47547B1 (en) | 1984-04-18 |
| FR2397395B1 (es) | 1981-01-16 |
| DK149454B (da) | 1986-06-16 |
| JPS5419934A (en) | 1979-02-15 |
| SE443789B (sv) | 1986-03-10 |
| AU3778078A (en) | 1980-01-10 |
| GB2001076B (en) | 1982-01-27 |
| FR2397395A1 (fr) | 1979-02-09 |
| DK149454C (da) | 1986-11-17 |
| GB2001076A (en) | 1979-01-24 |
| FI67367C (fi) | 1985-03-11 |
| FI67367B (fi) | 1984-11-30 |
| LU79960A1 (fr) | 1979-04-09 |
| NL7707781A (nl) | 1979-01-16 |
| AU519567B2 (en) | 1981-12-10 |
| US4203975A (en) | 1980-05-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2012480A1 (en) | Isolation and structural elucidation of the cytostatic linear depsipeptide dolastatin 15 | |
| MD1233B1 (en) | Erythromycin derivatives, process for their preparation and pharmaceutical composition on base thereof | |
| UA41446C2 (uk) | Застосування фумагілолу та його похідних для одержання ліків, призначених для боротьби з кишковими інфекціями, та фармацевтична композиція на їх основі | |
| BG108806A (en) | IIb/IIIa CELL ADHESION INHIIBITORS, METHOD FOR THE PRODUCTION, PHARMACEUTCIAL COMPOSITION AND ADMINISTRATION THEREOF | |
| MY100343A (en) | Amide derivative and external medicament comprising same | |
| MX9701538A (es) | Sales de un derivado del indol contra la migraña. | |
| DE3061693D1 (en) | Secondary amines, their preparation and use in pharmaceutical compositions | |
| EP0393494A3 (en) | Bile acid derivatives, processes for the preparation thereof and pharmaceutical compositions containing them | |
| PT79839B (en) | Process for the preparation of 6,6-ethylene-15,16-methylene-3-oxi-17alpha-pregn-4-ene-21,17-carbolactones and pharmaceutical compositions therewith | |
| ES471672A1 (es) | Un procedimiento para la preparacion de un peptido | |
| ES8303355A1 (es) | Procedimiento para la obtencion de nuevos derivados de mer- captoimidazoles. | |
| IL59603A (en) | Peptides having ubiquitin-like activity,their preparation and pharmaceutical compositions containing them | |
| ES460618A1 (es) | Procedimiento para la preparacion de derivados de peptido | |
| ES480113A1 (es) | Procedimiento para la preparacion de nuevos derivados de 2- iminoimidazolidina. | |
| DE3162053D1 (en) | N-acyl peptide compounds, processes for the preparation thereof and pharmaceutical compositions containing them | |
| ES478204A1 (es) | Un procedimiento para la preparacion de un peptido psicofar-macologicamente activo. | |
| IE790754L (en) | Substituted ethanolamines | |
| GB1498857A (en) | Antidepressant composition | |
| GB2008096A (en) | (2-Oxo-pyrrolidine-1)- and (2-oxo- piperidine-1) carboxylic acid hydrazides, process for the manufacture thereof, and pharmaceutical preparations containing them | |
| ES468293A1 (es) | Procedimiento para preparar derivados de a-nor-androsta-3 (5),16-dien-2-ona. | |
| ES8605819A1 (es) | Procedimiento de preparacion de nuevos derivados nucleosidos. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD1A | Patent lapsed |
Effective date: 19980202 |